Veritone (VERI) 10-Q 8 Aug 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Jul. 31, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Trading Symbol	VERI
Entity Registrant Name	Veritone, Inc.
Entity Central Index Key	1,615,165
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		14,957,268

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
ASSETS
Cash and cash equivalents	$ 65,912	$ 12,078
Accounts receivable, net of allowance for doubtful accounts of $67 and $0, respectively	12,243	4,834
Expenditures billable to clients	8,302	3,384
Prepaid expenses and other current assets	2,374	1,071
Total current assets	88,831	21,367
Property, equipment and improvements, net	46	68
Capitalized software, net	225	321
Other assets	169	592
Total assets	89,271	22,348
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable	18,564	12,321
Accrued media payments	8,983	6,777
Other accrued liabilities	3,110	3,060
Customer advances	3,089	1,841
Convertible notes payable, net of discounts and issuance costs of $0 and $6,898, respectively		13,388
Warrant liability		7,114
Total current liabilities	33,746	44,501
Other liabilities	18	22
Total liabilities	33,764	44,523
Commitments and contingencies (Note 7)
Redeemable convertible preferred stock:
Total redeemable convertible preferred stock		23,350
Stockholders' equity (deficit):
Preferred stock, par value $0.001 per share; 1,000,000 shares authorized at June 30, 2017; no shares issued and outstanding at June 30, 2017
Common stock, par value $0.001 per share; 75,000,000 and 38,500,000 shares authorized at June 30, 2017 and December 31, 2016, respectively; 14,956,068 and 2,620,803 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	15	4
Additional paid-in capital	132,640	(293)
Accumulated deficit	(77,148)	(45,236)
Total stockholders' equity (deficit)	55,507	(45,525)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)	$ 89,271	22,348
Series B Redeemable Convertible Preferred Stock [Member]
Redeemable convertible preferred stock:
Total redeemable convertible preferred stock		17,897
Series A Redeemable Convertible Preferred Stock [Member]
Redeemable convertible preferred stock:
Total redeemable convertible preferred stock		$ 5,453

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Allowance for doubtful accounts	$ 67,000	$ 0
Convertible notes payable, discounts	$ 0	$ 6,898,000
Preferred stock, par value	$ 0.001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	38,500,000
Common stock, shares issued	14,956,068	2,620,803
Common stock, shares outstanding	14,956,068	2,620,803
Series B Redeemable Convertible Preferred Stock [Member]
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, authorized	0	3,092,781
Preferred Stock, issued	0	3,092,781
Preferred Stock, outstanding	0	3,092,781
Preferred Stock, liquidation preference		$ 18,138,000
Series A Redeemable Convertible Preferred Stock [Member]
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, authorized	0	5,666,667
Preferred Stock, issued	0	5,666,667
Preferred Stock, outstanding	0	5,666,667
Preferred Stock, liquidation preference		$ 8,353,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Net revenues	$ 4,087	$ 2,011	$ 7,195	$ 4,087
Cost of revenues	336	299	532	619
Gross profit	3,751	1,712	6,663	3,468
Operating expenses:
Selling and marketing	3,414	1,840	6,013	3,486
Research and development	2,883	1,646	6,147	3,176
General and administrative	5,302	4,754	8,982	7,264
Total operating expenses	11,599	8,240	21,142	13,926
Loss from operations	(7,848)	(6,528)	(14,479)	(10,458)
Other income (expense), net	(13,746)	4	(12,960)	(27)
Loss before provision for income taxes	(21,594)	(6,524)	(27,439)	(10,485)
Provision for income taxes	1	1	3	3
Net loss	(21,595)	(6,525)	(27,442)	(10,488)
Accretion of redeemable convertible preferred stock	(3,397)	(794)	(4,470)	(1,588)
Net loss attributable to common stockholders	$ (24,992)	$ (7,319)	$ (31,912)	$ (12,076)
Net loss per share attributable to common stockholders:
Basic and diluted	$ (2.94)	$ (3.20)	$ (5.82)	$ (6.89)
Weighted average shares outstanding attributable to common stockholders:
Basic and diluted	8,491,391	2,284,098	5,484,379	1,753,629

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Stockholders' Equity (Deficit) - 6 months ended Jun. 30, 2017 - USD ($) $ in Thousands	Total	Initial Public Offering [Member]	Bridge Loan [Member]	Bridge Loan [Member]Initial Public Offering [Member]	Series B Redeemable Convertible Preferred Stock [Member]	Series B Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Series A Redeemable Convertible Preferred Stock [Member]	Series A Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Acacia Note [Member]Initial Public Offering [Member]	Common Stock [Member]	Common Stock [Member]Initial Public Offering [Member]	Common Stock [Member]Bridge Loan [Member]	Common Stock [Member]Bridge Loan [Member]Initial Public Offering [Member]	Common Stock [Member]Series B Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Common Stock [Member]Series A Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Common Stock [Member]Acacia Note [Member]Initial Public Offering [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]Initial Public Offering [Member]	Additional Paid-in Capital [Member]Bridge Loan [Member]	Additional Paid-in Capital [Member]Bridge Loan [Member]Initial Public Offering [Member]	Additional Paid-in Capital [Member]Series B Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Additional Paid-in Capital [Member]Series A Redeemable Convertible Preferred Stock [Member]Initial Public Offering [Member]	Additional Paid-in Capital [Member]Acacia Note [Member]Initial Public Offering [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2016	$ (45,525)									$ 4							$ (293)							$ (45,236)
Beginning balance, shares at Dec. 31, 2016										2,620,803
Issuance of common stock		$ 32,534	$ 3,666								$ 3	$ 0						$ 32,531	$ 3,666
Issuance of common stock, shares	12,335,265	2,500,000									2,500,000	300,000
Conversion of preferred stock upon public offering						$ 18,668		$ 8,598						$ 2	$ 3						$ 18,666	$ 8,595
Conversion of preferred stock upon public offering, shares					2,309,135		2,922,798							2,309,135	2,922,798
Exercise of Primary Warrant upon public offering		$ 29,263									$ 2							$ 29,261
Exercise of Primary Warrant upon public offering, shares											2,150,335
Conversion of debt and accrued interest upon public offering				$ 8,045					$ 20,737				$ 1			$ 2				$ 8,044			$ 20,735
Conversion of debt and accrued interest upon public offering, shares			590,717										590,717			1,523,746
Issuance of restricted stock	$ 0									$ 0							0							0
Issuance of restricted stock, shares										34,333
Repurchase of common stock	(56)									$ 0							(56)
Repurchase of common stock, shares										(7,500)
Exercise of options	$ 3									$ (2)							5
Exercise of options, shares	1,580									1,580
Issuance of warrants	$ 8,658																8,658
Beneficial conversion feature	554																554
Modification of warrants	371																371
Stock-based compensation expense	1,903																1,903
Accretion of redeemable convertible preferred stock	(4,470)																							(4,470)
Net loss	(27,442)																							(27,442)
Ending balance at Jun. 30, 2017	$ 55,507									$ 15							$ 132,640							$ (77,148)
Ending balance, shares at Jun. 30, 2017										14,956,068

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (27,442)	$ (10,488)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	119	61
Intangible asset impairment charges		500
Amortization of debt discounts and issuance costs	3,740
Costs of warrants issued at IPO	5,790
Write-off of debt discounts and issuance costs at IPO	10,132
Change in fair value of warrant liability	(7,114)
Provision for doubtful accounts	67
Stock-based compensation expense	1,903	1,522
Changes in assets and liabilities:
Accounts receivable	(7,476)	(379)
Expenditures billable to clients	(4,918)	(2,818)
Prepaid expenses and other current assets	(1,303)	(284)
Accounts payable	6,042	(4,810)
Accrued media payments	2,206	1,051
Other accrued liabilities	529	127
Customer advances	1,248	(94)
Net cash used in operating activities	(16,477)	(15,612)
Cash flows from investing activities:
Addition to intangible assets	(30)
Net cash used in investing activities	(30)
Cash flows from financing activities:
Net proceeds from public offering	33,199
Proceeds received under the Bridge Loan Agreement	8,000
Proceeds from exercise of Primary Warrant	29,263
Proceeds from exercise of stock options	3
Debt issuance costs	(68)
Repurchase of common stock	(56)
Net cash provided by financing activities	70,341
Net increase (decrease) in cash and cash equivalents	53,834	(15,612)
Cash and cash equivalents, beginning of period	12,078	19,197
Cash and cash equivalents, end of period	65,912	$ 3,585
Non-cash investing and financing activities:
Conversion of convertible notes payable, including accrued interest, to common stock	28,782
Conversion of redeemable convertible preferred stock to common stock	27,266
Unpaid deferred IPO costs	$ 665

Description of Business and Bas

Description of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Description of Business and Basis of Presentation	Note 1. Description of Business and Basis of Presentation Description of Business Veritone, Inc., a Delaware corporation, (“Veritone”) (together with its wholly-owned subsidiaries, collectively, the Company) is a cloud-based cognitive software company that extracts understanding from unstructured audio and video data. The Company’s platform incorporates patented technology to manage and integrate a wide variety of artificial intelligence processes, through the orchestration of machine learning algorithms known as cognitive engines to mimic human cognitive functions such as perception, reasoning, prediction and problem solving to transform unstructured data. The Company’s artificial intelligence (“AI”) platform stores the cognitive engine results in a searchable, time-correlated index, creating an online, searchable library of audio and video data that enables analysis and automated business solutions. Because of its open architecture, additional cognitive engines can be readily added to the platform, and new applications can be added by the Company or third parties to leverage the platform for a broad range of industries that capture or use audio and video data, including, without limitation, media, politics, legal and other commercial and government vertical markets. In addition, the Company operates a full service advertising agency. The Company’s expertise in media buying, planning and creative development, coupled with its proprietary technology platform, enables the Company to deliver and analyze the effectiveness of advertising in a way that is simple, scalable and trackable. Initial Public Offering In May 2017, the Company completed an initial public offering (“IPO’) of its common stock. In connection with the IPO, the Company sold 2,500,000 shares of common stock at $15.00 per share for an expected aggregate net proceeds of $32,534 after underwriting discounts, commissions and offering costs of $4,966. Concurrent with the closing of the IPO on May 17, 2017, the following transactions were completed in accordance with the related agreements (see Notes 3 and 4): (a) The Series B Preferred Stock, which had a liquidation preference of $18,668 and a net book value of $18,463, was automatically converted into 2,309,135 shares of the Company’s common stock; (b) The Series A Preferred Stock, which had a liquidation preference of $8,598 and a net book value of $6,272, was automatically converted into 2,922,798 shares of the Company’s common stock; (c) The Convertible Note Payable to Acacia, which had a principal balance of $20,000 and accrued interest of $737, was automatically converted into 1,523,746 shares of the Company’s common stock; (d) The Primary Warrant was automatically exercised by Acacia, which resulted in the issuance of 2,150,335 shares of the Company’s common stock to Acacia in exchange for cash proceeds of $29,263; (e) The Lenders funded the remaining undrawn amounts under the Bridge Loan, which provided cash proceeds of $4,000 to the Company and increased the outstanding principal balance of the Bridge Loan to $8,000. In connection with the funding, the Company issued to the Bridge Loan Lenders (a) an aggregate of 90,000 shares of its common stock, and (b) fully vested warrants to purchase a number of shares of the Company’s common stock equal to the greater of (i) 120,000 shares of common stock, and (ii) 0.75% of the Company’s fully diluted shares outstanding following completion of the IPO. Such warrants have a term of ten years following the date of issuance and have an exercise price per share equal to the lower of $13.6088 or the IPO price per share to the public; (f) The Bridge Loan, which had a principal balance of $8,000 and accrued interest of $45, was automatically converted into an aggregate of 590,717 shares of the Company’s common stock; and (g) The warrants to purchase an aggregate of 240,000 shares of the Company’s common stock that were issued in connection with the Bridge Loan were automatically adjusted upon completion of the IPO to be exercisable to purchase an aggregate of 313,446 shares of the Company’s common stock (which was equal to 1.5% of the fully diluted shares of common stock outstanding immediately following the closing of the IPO). Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements presented in the Company’s final prospectus dated May 11, 2017 (the “Prospectus”) contained in the Company’s Registration Statement on Form S-1 No. 333-216726). The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal and recurring, necessary to fairly state its financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three-month and six-month Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the valuation of common stock, stock awards, and stock warrants. Actual results could differ from those estimates.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the Prospectus. Revenue Recognition Net revenues for the three- and six-month Three Months Ended June 30, Six Months Ended June 30, 2017 2016 2017 2016 Media agency revenues $ 3,739 $ 1,938 $ 6,638 $ 3,974 AI platform revenues 348 73 557 113 Total net revenues $ 4,087 $ 2,011 $ 7,195 $ 4,087 During the three months ended June 30, 2017 and 2016, the Company made $31,243 and $16,962 in gross media placements, of which $28,784 and $14,585, respectively, were billed directly to customers. Of the amounts billed directly to customers, $25,045 and $12,647 represented media-related costs netted against billings during the three months ended June 30, 2017 and 2016, respectively. For the six months ended June 30, 2017 and 2016, the Company made $57,485 and $35,037 in gross media placements, of which $48,207 and $29,608, respectively, were billed directly to customers. Of the amounts billed directly to customers, $41,569 and $25,634 represented media-related costs netted against billings for the six months ended June 30, 2017 and 2016, respectively. Other Income (Expense), Net Other income (expense), net for the three- and six-month periods presented were comprised of the following: Three Months Ended June 30, Six Months Ended June 30, 2017 2016 2017 2016 Interest income (expense), net $ (1,880 ) $ 1 $ (4,234 ) $ 4 Stock warrants issued (5,790 ) — (5,790 ) — Write-off of deferred debt discounts and issuance costs (10,132 ) — (10,132 ) — Gain on fair value change of warrant liability 3,996 — 7,114 — Other 60 3 82 (31 ) Other income (expense), net $ (13,746 ) $ 4 $ (12,960 ) $ (27 ) Interest expense, net for the three- and six-month periods ended June 30, 2017 included amortization of deferred debt discounts and issuance costs of $1,686 and $3,740, respectively, related to the Company’s convertible notes payable. Earnings Per Share The following table presents the computation of basic and diluted net loss per common share for the periods presented: Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss per share: Numerator Net loss $ (21,595 ) $ (6,525 ) $ (27,442 ) $ (10,488 ) Accretion of redeemable convertible preferred stock (3,397 ) (794 ) (4,470 ) (1,588 ) Net loss attributable to common stockholders $ (24,992 ) $ (7,319 ) $ (31,912 ) $ (12,076 ) Denominator Weighted-average common shares outstanding 8,666,147 2,424,554 5,679,024 1,862,401 Less: Weighted-average shares subject to repurchase (174,756 ) (140,456 ) (194,645 ) (108,772 ) Denominator for basic and diluted net loss 8,491,391 2,284,098 5,484,379 1,753,629 Basic and diluted net loss per share attributable to common stockholders $ (2.94 ) $ (3.20 ) $ (5.82 ) $ (6.89 ) Other potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in weighted-average common equivalent shares): Three Months Ended Six Months Ended 2017 2016 2017 2016 Common stock options 2,697,361 682,415 1,682,804 636,112 Warrants to purchase common stock 2,381,530 — 2,165,872 — Shares issuable upon conversion of redeemable convertible preferred stock — 4,828,800 — 4,783,800 Total 5,078,891 5,511,215 3,848,676 5,419,912 Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy, which is based on three levels of inputs, the first two of which are considered observable and the last unobservable, that may be used to measure fair value, is as follows: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s financial instruments, other than its stock warrants, consist primarily of cash and cash equivalents, accounts receivable, accounts payable and convertible notes payable. The Company has determined that the carrying values of these instruments for the periods presented approximate fair value due to their short-term nature and the relatively stable current interest rate environment. The Company’s stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using a probability-weighted expected return model. This model incorporates contractual terms, maturity, risk free rates and volatility. The value of the Company’s stock warrants would increase if a higher risk free interest rate were used, and the value of the Company’s stock warrants would decrease if a lower risk free interest rate were used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The unobservable inputs for Level 3 fair value measurements and fair value calculations are developed and determined by the Company’s management with the assistance of a third party valuation specialist. The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s stock warrants that are categorized as Level 3 within the fair value hierarchy: December 31, 2016 Volatility 80.0 % Risk free rate 1.84 % Discount for lack of marketability 20.0 % The following table represents a reconciliation of the Level 3 measurement of the Company’s Primary Warrant (see related discussion in Note 3): Balance, December 31, 2016 $ 7,114 Less: Change in fair value of warrant liability (7,114 ) Balance, June 30, 2017 $ — In addition, in May 2017, upon exercise of the Primary Warrant, the Company issued to Acacia a five-year warrant to purchase 809,400 shares of the Company’s common stock, or 10% Warrant. The fair value of the 10% Warrant under Level 3 measurement is $5,790 (see related discussion in Note 3). The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s 10% Warrant that are categorized as Level 3 within the fair value hierarchy: May 17, 2017 Volatility 70.0 % Risk free rate 1.44 % Discount for lack of marketability 0 % Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, 2014-09 2014-09 2014-09: No. 2016-08, No. 2016-10, No. 2016-12, 2016-20, 2016-08, 2016-10, 2016-12 2016-20 2014-09 In November 2015, the FASB issued ASU No. 2015–17, “Income Taxes: Balance Sheet Classification of Deferred Taxes (Topic 740),” to require that deferred tax liabilities and assets be classified entirely as non-current. In February 2016, the FASB issued ASU No. 2016-02, right-of-use right-of-use In March 2016, the FASB issued ASU No. 2016-09, 2016-09 In August 2016, the FASB issued ASU 2016-15, In May 2017, the FASB issued ASU No. 2017-09, 2017-09

Convertible Notes Payable and R

Convertible Notes Payable and Related Transactions	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Convertible Notes Payable and Related Transactions	NOTE 3. CONVERTIBLE NOTES PAYABLE AND RELATED TRANSACTIONS Acacia Note In March 2017, the Company and Acacia Research Corporation (“Acacia”) amended certain terms of the warrants that were included in the Investment Agreement that was entered into by the two companies on August 15, 2016 (refer to the Company’s Prospectus for the full discussion of the Investment Agreement). Under the terms of the amendments, if the Company completed an IPO of its common stock with gross proceeds of at least $15,000 (a “Qualifying IPO”), the exercise price for all warrants issued to Acacia would be the lower of $13.6088 or the price of common stock issued in the IPO (see discussion of the IPO in Note 1). Also, the primary common stock purchase warrant issued to Acacia on August 15, 2016, as amended (the “Primary Warrant”) would automatically be exercised upon the completion of a Qualifying IPO. As a result of these amendments, the fair value of the Primary Warrant decreased by $3,118 and the credit associated with the reduction in fair value was recorded as a gain in Other Income (Expense) in the Company’s condensed consolidated statement of operations for the first quarter of 2017. Concurrent with the closing of the IPO on May 17, 2017, the convertible note payable to Acacia (the “Acacia Note”), which had a principal balance of $20,000 and accumulated accrued interest of $737, was automatically converted into 1,523,746 shares of the Company’s common stock at a conversion price per share of $13.6088. As a result of the conversion of the Acacia Note, the Company recorded a charge to earnings of $4,347 representing the write-off Also, concurrent with the closing of the IPO, the Primary Warrant was automatically exercised by Acacia at an exercise price of $13.6088 per share, which resulted in the issuance of 2,150,335 shares of the Company’s common stock in exchange for a cash proceeds of $29,263. Upon such exercise of the Primary Warrant, the Company issued to Acacia a five-year warrant to purchase 809,400 shares of the Company’s common stock at an exercise price of $13.6088 per share (the “10% Warrant”). Fifty percent of the shares under the 10% Warrant vested upon its issuance and the remaining half will vest in May 2018. The fair market value of the 10% Warrant is $5,790, which was recorded as an expense in Other Income (Expense) in the Company’s condensed consolidated statement of operations for the second quarter of 2017. Moreover, as a result of the exercise of the Primary Warrant, the balance of the Warrant Liability of $3,996 was written-off Bridge Loan In March 2017, the Company entered into a Note Purchase Agreement with Acacia and Veritone LOC I, LLC (“VLOC”) (collectively, the “Lenders”), which provided for a line of credit of up to $8,000 (the “Bridge Loan”). The convertible promissory notes issued to the Lenders pursuant to the Bridge Loan accrued interest at the rate of eight percent (8%) per annum, compounded quarterly. The borrowings were due and payable on November 25, 2017, and the Company’s obligations under this facility were secured by a security interest in substantially all of the assets of the Company, which was of equal priority to the security interests of Acacia under the Acacia Note. The Company drew down the initial $2,000 installment under the Bridge Loan upon the execution of the Note Purchase Agreement. In April 2017, the Company borrowed an additional $2,000 under the Bridge Loan. In May 2017, the Lenders funded the remaining undrawn amounts of $4,000 under the Bridge Loan, which increased the outstanding principal balance of the Bridge Loan to $8,000. Upon the execution of the Note Purchase Agreement, the Company issued an aggregate of 120,000 shares of the Company’s common stock to the Lenders in accordance with the agreement. In addition, in connection with the funding of the $8,000 principal amount of the Bridge Loan, the Company issued to the Lenders an aggregate of 180,000 shares of the Company’s common stock and warrants to purchase an aggregate of 240,000 shares of common stock. Such warrants were automatically adjusted upon completion of the IPO to be exercisable to purchase an aggregate of 313,446 shares of the Company’s common stock (which was equal to 1.5% of the fully diluted shares of common stock outstanding immediately following the closing of the IPO). The warrants have a term of ten years following the date of issuance and have an exercise price of $13.6088 per share. As of June 30, 2017, no warrants issued in connection with the Bridge Loan had been exercised. The members of VLOC include entities controlled by Chad Steelberg and Ryan Steelberg, the Company’s Chief Executive Officer and President, respectively, who own 50% of the VLOC’s membership interests, and certain holders of the Company’s redeemable convertible preferred stock. Concurrent with the closing of the IPO on May 17, 2017, the $8,000 principal balance of the Bridge Loan and accumulated accrued interest of $45, were automatically converted into an aggregate of 590,717 shares of the Company’s common stock at a conversion price per share of $13.6088. As a result of the conversion of the Bridge Loan, the Company recorded a charge to earnings of $2,915, representing the unamortized balance of the debt discounts associated with the common stock and warrants issued during the signing of the agreement and the debt issuance costs related to the March and April 2017 borrowings. The Company presented the write-off Paid-in The following table represents a reconciliation of the principal amounts of the Acacia Note and the Bridge Loan (as described above) to the convertible notes payable included in the Company’s condensed consolidated balance sheets as of: June 30, December 31, First Loan principal, August 15, 2016 $ — $ 10,000 Second Loan principal, November 25, 2016 — 10,000 Debt discounts associated with stock warrants, net — (6,793 ) Debt issuance costs, net — (105 ) Accrued interest — 286 Convertible note payable $ — $ 13,388

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock	6 Months Ended
	Jun. 30, 2017
Accounting Changes and Error Corrections [Abstract]
Redeemable Convertible Preferred Stock	NOTE 4. REDEEMABLE CONVERTIBLE PREFERRED STOCK Concurrent with the closing of the IPO on May 17, 2017, the Series B Preferred Stock, which had a liquidation preference of $18,668 and a net book value of $18,463, was automatically converted into 2,309,135 shares of the Company’s common stock, and the Series A Preferred Stock, which had a liquidation preference of $8,598 and a net book value of $6,272, was automatically converted into 2,922,798 shares of the Company’s common stock. The differences between the liquidation preference and book value of the Series B and Series A Preferred Stock of $205 and $2,326, respectively, were recorded as a debit to accretion of redeemable convertible preferred stock in the Company’s condensed statement of operations for the second quarter of 2017 and an increase to Additional Paid-in In the first quarter of 2017, the Company had recorded the amount of the beneficial conversion feature of the Series B and Series A Preferred Stock amounting to $226 and $328, respectively, as the respective conversion prices for such shares were less than the fair market value of the underlying preferred stock. The beneficial conversion feature resulted in the recording of a discount against the preferred stock and a corresponding credit to the Company’s additional paid-in write-off In May 2017, the Board of Directors and the stockholders of the Company approved the decrease in the Company’s authorized preferred stock from 11,500,000 shares to 1,000,000 shares (par value $0.001 per share), effective following the closing of the IPO and the filing of the Company’s amended and restated certificate of incorporation.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Stockholders' Equity (Deficit)	NOTE 5. STOCKHOLDERS’ EQUITY (DEFICIT) Reverse Split In April 2017, the Company’s Board of Directors and stockholders approved a 0.6-for-1.0 Common Stock In May 2017, the Board of Directors and the Company’s stockholders approved the increase in the Company’s authorized common stock to 75,000,000 shares from 38,500,000 shares (par value $0.001 per share), effective following the closing of the IPO and the filing of the Company’s amended and restated certificate of incorporation. During the six months ended June 30, 2017, the Company issued 12,335,265 shares of common stock as follows: (a) 120,000 shares to the Bridge Loan Lenders upon execution of the Note Purchase Agreement in March 2017, (b) 90,000 shares in connection with the $2,000 Bridge Loan borrowings in March and April 2017, (c) 2,500,000 shares for the IPO, (d) 2,309,135 shares for the conversion of the Series B preferred stock upon public offering, (e) 2,922,798 shares for the conversion of the Series A preferred stock upon public offering, (f) 2,150,335 shares for the exercise of the Primary Warrant upon public offering, (g) 1,523,746 shares for the conversion of the Acacia Note and accrued interest upon the IPO, (h) 590,717 shares for the conversion of the Bridge Loan and accrued interest upon the IPO, and (i) 90,000 shares in connection with the $4,000 Bridge Loan borrowing in May 2017. Also, the Company issued under its 2014 Plan Stock Options/Stock Issuance Plan (the “2014 Plan”) 9,500 shares of restricted common stock to employees, 17,333 shares of restricted common stock to consultants for payment of services rendered, 10,121 shares of common stock to the Company’s CEO as compensation for the second quarter of 2017 (see Note 7) and 1,580 shares upon the exercise of stock options (see Condensed Consolidated Statement of Stockholders Equity (Deficit) for more details). Common Stock Warrants Upon signing of the Investment Agreement and in conjunction with the Company’s First Loan with Acacia, the Company issued to Acacia a four-year warrant to purchase a number of shares of its common stock determined by dividing $700,000 by an exercise price per share ranging from $8.0833 to $13.7323, with the actual exercise price to be determined by the type and/or valuation of its future equity financings. In conjunction with the Second Loan in November 2016, the Company issued to Acacia two additional four-year warrants, each to purchase a number of shares of the Company’s common stock determined by dividing $700,000 by an exercise price per share ranging from $8.0833 to $13.7323, with the actual exercise price to be determined by the type and/or valuation of its future equity financings). In March 2017, in connection with the amendment of the Primary Warrant, each of these warrants was amended to provide that the exercise prices thereof shall be equal to the lower of $13.6088 or the initial public offering price per share. As a result, upon completion of the IPO on May 17, 2017, each of these three warrants became exercisable to purchase up to 51,437 shares of common stock, or an aggregate of 154,311 shares of common stock, at an exercise price per share of $13.6088. In addition, upon the automatic exercise in full of the Primary Warrant, the Company issued to Acacia the 10% Warrant, which is a five-year warrant, to purchase 809,400 shares of the Company’s common stock at an exercise price of $13.6088 per share. Fifty percent of the shares under the 10% Warrant vested upon its issuance and the remaining fifty percent will vest in May 2018. The Company had also issued to the Bridge Loan Lenders in connection with the Bridge Loan warrants to purchase an aggregate of 313,446 shares of the Company’s common stock. Such warrants have a term of ten years following the individual issuance dates and have an exercise price per share equal to $13.6088. As of June 30, 2017, the Company had a total of 1,277,157 of warrants issued and outstanding. Dispute Settlement On December 23, 2016, the Company entered into a settlement agreement and release relating to certain claims by a former employee, pursuant to which the Company paid to the former employee a lump sum cash payment of $350 on January 4, 2017, which included a payment to the former employee to repurchase 7,500 shares of the Company’s common stock in the amount of $56, representing the fair value of such stock at that time. In addition, pursuant to the settlement agreement, Chad Steelberg, the Company’s Chairman of the Board and Chief Executive Officer, purchased all of the former employee’s membership interests in VIF I, LLC, a minority stockholder in the Company. Stock-Based Compensation In 2014, the Company’s Board of Directors and its stockholders adopted the 2014 Plan, which was amended in March 2015, October 2016 and April 2017. The 2014 Plan is administered by the compensation committee of the Board of Directors, which determines the recipients and the terms of the awards granted. The Plan provides that awards granted may be options, restricted stock or restricted stock units. Stock option awards may be either incentive stock options or non-qualified During the second quarter of 2017, the Company granted the following equity awards to employees, directors and consultants under the 2014 Plan: • A total of 2,089,638 time-vested stock options were granted pursuant to the Employment Agreements with Chad Steelberg and Ryan Steelberg, which have an exercise price of $15.00 per share and a three-year vesting period; • A total of 1,044,818 performance-based stock options were granted pursuant to the Employment Agreements with Chad Steelberg and Ryan Steelberg, which have an exercise price of $15.00 per share. The performance-based stock option would vest upon the earlier of (a) the first date on which the market capitalization of the Company’s common stock equals or exceeds $400,000 over five consecutive business days, or (b) five years after the IPO; and • A total of 666,702 stock options were granted to other employees and directors under the 2014 Plan, which have an exercise price of $15.00 per share and a four-year vesting period. The Company’s Board of Directors has resolved not to make any further awards under the 2014 Plan following the completion of the Company’s IPO. The 2014 Plan will continue to govern all outstanding awards granted thereunder. In April 2017, the Company’s Board of Directors and stockholders approved and adopted the 2017 Stock Incentive Plan (the “2017 Plan”), which became effective upon the execution of the underwriting agreement in connection with the Company’s IPO. The 2017 Plan is administered by the compensation committee of the Board of Directors, which determines the recipients and the terms of the awards granted. Under the 2017 Plan, employees, non-employee In the second quarter of 2017, under the 2017 Plan, the Company awarded to members of the Board of Directors 35,576 restricted stock units with a weighted average grant price of $14.76. As of June 30, 2017, an aggregate of 1,964,424 shares of common stock were available for future grant under the 2017 Plan. The Company recognizes compensation expense relating to awards granted under the 2014 and 2017 Plans ratably over the requisite service period, which is generally the vesting period. Expected forfeitures (currently at ten percent) are estimated based on historical and estimated future turnover of the Company’s employees. The Company’s stock-based compensation expense for the three and six months ended June 30, 2017, including expense for non-employees Three Months Ended Six Months Ended 2017 2016 2017 2016 Stock-based compensation expense by type of award: Restricted stock $ 375 $ 28 $ 451 $ 48 Common stock awards 125 — 125 — Stock options 1,278 1,453 1,327 1,474 Total $ 1,778 $ 1,481 $ 1,903 $ 1,522 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 116 $ 24 $ 155 $ 48 Research and development 92 6 104 12 General and administrative 1,570 1,451 1,644 1,462 Total $ 1,778 $ 1,481 $ 1,903 $ 1,522 Restricted Stock Under the 2014 Plan, the Company has granted restricted stock that generally vests over four years from the date of the grant, unless the participant’s service with the Company is terminated earlier. The fair value of the restricted stock grants was the estimated value per share of common stock at the date of grant determined by using both the option-pricing method and probability-weighted expected return method. Following the IPO, the fair value of the restricted stock granted is based on the closing market price of the Company’s common stock at the grant date. Restricted stock activity for the period presented was as follows: Shares Weighted Unvested at December 31, 2016 208,886 $ 4.80 Granted 52,433 $ 14.79 Forfeited (18,100 ) $ 10.03 Vested (62,313 ) $ 8.16 Unvested at June 30, 2017 180,906 $ 6.01 At June 30, 2017, total unrecognized compensation cost related to restricted stock was $1,088, which is expected to be recognized over 2.7 years. Stock Options Under the 2014 Plan, the Company has granted stock options at exercise prices equal to or greater than the fair value of the common stock on the grant date. These options expire ten years after the grant date and generally vest over a period of four years of continuous service following the vesting commencement date of such option (except for certain options granted to Chad Steelberg and Ryan Steelberg pursuant to their Employment Agreements), unless the optionee’s continuous service with the Company is terminated earlier, with stock-based compensation expense recognized evenly over the requisite service period. The fair value for each option granted was determined as of the grant date using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires various assumptions, which are noted in the following table: Six Months Ended Expected terms (in years) 5.83 - 6.08 Expected volatility 65% Risk-free interest rate 1.89% - 2.20% Expected dividend yield — The expected term reflects the application of the simplified method. The simplified method defines the expected term as the average of the contractual term of the options and the vesting period for all tranches. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award. Estimated volatility reflects historical volatility of the shares of publicly-traded peers of the Company until sufficient information regarding the volatility of the Company’s shares becomes available. The Company’s stock option activity for the period presented was as follows: Weighted-Average Options Exercise Remaining Aggregate Outstanding at December 31, 2016 680,434 $ 2.27 8.49 years $ 3,031 Options Granted 3,801,158 $ 15.00 Options Exercised (1,580 ) $ 1.93 Options Forfeited / Cancelled (48,905 ) $ 2.88 Outstanding at June 30, 2017 4,431,107 $ 13.17 8.33 years $ 5,972 Exercisable at June 30, 2017 350,716 The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock and the average option exercise price of in-the-money Employee Stock Purchase Plan In April 2017, the Company’s Board of Directors and stockholders approved and adopted the employee stock purchase plan (the “ESPP”), which became effective upon the execution of the underwriting agreement in connection with the Company’s IPO. The ESPP is administered by the compensation committee of the Board of Directors and is intended to qualify as an employee stock purchase plan under Section 423 of the Code. The purchase price for shares of the Company’s common stock under the ESPP will be established by the plan administrator prior to the start of the offering period, but will not be less than 85% of the lower of the fair market value of the Company’s common stock on (i) the date the eligible employee enters an offering period and (ii) the purchase date. Each purchase right granted to an employee will provide an employee with the right to purchase up to 1,000 shares of common stock on each purchase date within the offering period. The Company has initially reserved 1,000,000 shares of its common stock for issuance under the ESPP. The share reserve will increase automatically on the first trading day of January each calendar year, beginning with calendar year 2018, by an amount equal to 1% of the total number of shares of common stock outstanding on the last trading day in December of the immediately preceding calendar year, up to an annual maximum of 250,000 shares. As of June 30, 2017, no shares of common stock were purchased by the Company’s employees under the ESPP.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 6. RELATED PARTY TRANSACTIONS In October 2014, the Company and Steel Ventures, LLC (“SVL”), an affiliated company whose shareholder has significant control over the Company, entered into an Intercompany Administrative Services Agreement (the “Service Agreement”) effective October 1, 2014 for a two-year two-year As fully discussed in the Prospectus, pursuant to the Investment Agreement, in August 2016, the Company entered into the Acacia Note, which provided for up to $20,000 in borrowings through two $10,000 advances, each bearing interest at the rate of 6.0% per annum. In August 2016, the Company borrowed the First Loan in an amount of $10,000 that initially had a one-year one-year In addition, in conjunction with the First Loan, the Company issued Acacia a four-year warrant to purchase a number of shares of its common stock determined by dividing $700 by an exercise price per share ranging from $8.0833 to $13.7323, with the actual exercise price to be determined by the type and/or valuation of our future equity financings. In conjunction with the Second Loan in November 2016, the Company issued to Acacia two additional four-year warrants, each to purchase a number of shares of its common stock determined by dividing $700 by an exercise price per share ranging from $8.0833 to $13.7323, with the actual exercise price to be determined by the type and/or valuation of our future equity financings). In March 2017, in connection with the amendment of the Primary Warrant, each of these warrants was amended to provide that the exercise prices thereof shall be equal to the lower of $13.6088 or the initial public offering price per share. As a result, upon completion of the IPO, each of these three warrants became exercisable to purchase 51,437 shares of common stock, or an aggregate of 154,311 shares of common stock, at an exercise price per share of $13.6088. Upon the exercise in full of the Primary Warrant in connection with the IPO, the Company issued to Acacia the 10% Warrant, with a term of five years, which provided for the issuance of 809,400 shares of our common stock at an exercise price of $13.6088 per share, with fifty percent of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant and the remaining fifty percent of the shares vesting on the first anniversary of the issuance date of the 10% Warrant. Acacia’s Chairman of the Board is a member of the Company’s Board of Directors. As discussed in Note 3, the Company entered into the Note Purchase Agreement with Acacia and VLOC, which provided for an $8,000 line of credit pursuant to Bridge Notes that accrue interest at the rate of eight percent (8%) per year, compounded quarterly, with Acacia and VLOC each purchasing equal amounts of such Bridge Notes. The Company borrowed the initial $2,000 installment under the Bridge Loan in March 2017, and borrowed the second $2,000 installment in April 2017. Prior to the completion of the IPO, the Lenders exercised their options to advance the remaining $4,000 remaining available under the Bridge Loan. Upon the completion of the IPO, all of the $8,000 principal and all accrued interest under the Bridge Notes were automatically converted into an aggregate of 590,717 shares of the Company’s common stock at a conversion price of $13.6088 per share. In connection with the Bridge Loan, the Company issued an aggregate of 120,000 shares of the Company’s common stock to the Lenders upon the execution of the Note Purchase Agreement. In addition, upon the full funding of $8,000 Bridge Loan, the Company had issued to the Lenders in the aggregate (a) 180,000 shares of the Company’s common stock, and (b) fully vested ten year warrants to purchase an aggregate of 313,446 of shares of the Company’s common stock. Such warrants have a ten-year In March 2017, the Company entered into employment agreements with Chad Steelberg and Ryan Steelberg, who are executive officers of the Company (see Note 7 for the full discussions of the agreements). The Company reimburses Chad Steelberg and Ryan Steelberg for the costs of their healthcare plans. During the three months ended June 30, 2017 and 2016, the Company expensed $14 and $15 for the cost of such plans, respectively. For the six months ended June 30, 2017 and 2016, the Company expensed $29 and $44 for the cost of such plans, respectively. As of June 30, 2017 and December 31, 2016, the Company had recorded an accrual of $0 and $73, respectively, related to these healthcare plans. There were no other related party balances and transactions as of and for the six months ended June 30, 2017.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 7. COMMITMENTS AND CONTINGENCIES Stockholders’ Employment Agreements In March 2017, the Company entered into three-year employment agreements with each of Chad Steelberg, the Company’s Chief Executive Officer, and Ryan Steelberg, the Company’s President. Under the agreement with Chad Steelberg, as of the end of each calendar quarter during the term of the agreement (following March 31, 2017) during which Chad Steelberg is still employed by the Company, the Company will issue to Mr. Steelberg a number of shares of its common stock calculated by dividing $125 by the fair market value (as defined in the agreement) of the Company’s common stock. The agreement with Ryan Steelberg provides that he shall receive an annual salary of $350. During the three months ended June 30, 2017, Chad Steelberg received 10,121 shares of common stock valued at $125. The employment agreements also provided that the Company would issue time-based stock options to Chad Steelberg and Ryan Steelberg to allow each of them to purchase a number of shares of the Company’s common stock equal to five percent of the fully diluted shares outstanding as of the closing of the Company’s IPO. The exercise price per share of such time-based stock option is the IPO price of the Company’s common stock ($15), and such options would vest in monthly increments ratably over the three-year period following the closing date of the IPO (May 17, 2017). In addition, the employment agreements provided that the Company would issue to each of Chad Steelberg and Ryan Steelberg a performance-based stock option, which would allow each of them to purchase a number of shares of the Company’s common stock equal to two and one-half The stock options issuable under the Employment Agreements with Chad Steelberg and Ryan Steelberg were issued at the time of the pricing of the IPO. The total number of time-vested stock options awarded under these agreements was 2,089,638 and the total number of performance-based options awarded was 1,044,818.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	NOTE 8. SUBSEQUENT EVENTS The Company evaluated subsequent events through August 7, 2017, the date these condensed consolidated financial statements were issued. On July 24, 2017, the Company entered into an office building lease agreement for its Corporate Headquarters. The lease provides for the lease by the Company of approximately 37,875 square feet of office space in Costa Mesa, California. The lease has an initial term of 82 months and the Company has the option to extend the lease for two terms of five years each. Total minimum lease payments over the lease term is approximately $9,465, net of abatements, of which approximately $123 is expected to be paid over the next twelve months ending June 30, 2018. There were no other material subsequent events that required recognition or additional disclosure in the accompanying condensed consolidated financial statements.

Summary of Significant Accoun15

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition Net revenues for the three- and six-month Three Months Ended June 30, Six Months Ended June 30, 2017 2016 2017 2016 Media agency revenues $ 3,739 $ 1,938 $ 6,638 $ 3,974 AI platform revenues 348 73 557 113 Total net revenues $ 4,087 $ 2,011 $ 7,195 $ 4,087 During the three months ended June 30, 2017 and 2016, the Company made $31,243 and $16,962 in gross media placements, of which $28,784 and $14,585, respectively, were billed directly to customers. Of the amounts billed directly to customers, $25,045 and $12,647 represented media-related costs netted against billings during the three months ended June 30, 2017 and 2016, respectively. For the six months ended June 30, 2017 and 2016, the Company made $57,485 and $35,037 in gross media placements, of which $48,207 and $29,608, respectively, were billed directly to customers. Of the amounts billed directly to customers, $41,569 and $25,634 represented media-related costs netted against billings for the six months ended June 30, 2017 and 2016, respectively.
Earnings Per Share	Earnings Per Share The following table presents the computation of basic and diluted net loss per common share for the periods presented: Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss per share: Numerator Net loss $ (21,595 ) $ (6,525 ) $ (27,442 ) $ (10,488 ) Accretion of redeemable convertible preferred stock (3,397 ) (794 ) (4,470 ) (1,588 ) Net loss attributable to common stockholders $ (24,992 ) $ (7,319 ) $ (31,912 ) $ (12,076 ) Denominator Weighted-average common shares outstanding 8,666,147 2,424,554 5,679,024 1,862,401 Less: Weighted-average shares subject to repurchase (174,756 ) (140,456 ) (194,645 ) (108,772 ) Denominator for basic and diluted net loss 8,491,391 2,284,098 5,484,379 1,753,629 Basic and diluted net loss per share attributable to common stockholders $ (2.94 ) $ (3.20 ) $ (5.82 ) $ (6.89 ) Other potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in weighted-average common equivalent shares): Three Months Ended Six Months Ended 2017 2016 2017 2016 Common stock options 2,697,361 682,415 1,682,804 636,112 Warrants to purchase common stock 2,381,530 — 2,165,872 — Shares issuable upon conversion of redeemable convertible preferred stock — 4,828,800 — 4,783,800 Total 5,078,891 5,511,215 3,848,676 5,419,912
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy, which is based on three levels of inputs, the first two of which are considered observable and the last unobservable, that may be used to measure fair value, is as follows: • Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s financial instruments, other than its stock warrants, consist primarily of cash and cash equivalents, accounts receivable, accounts payable and convertible notes payable. The Company has determined that the carrying values of these instruments for the periods presented approximate fair value due to their short-term nature and the relatively stable current interest rate environment. The Company’s stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using a probability-weighted expected return model. This model incorporates contractual terms, maturity, risk free rates and volatility. The value of the Company’s stock warrants would increase if a higher risk free interest rate were used, and the value of the Company’s stock warrants would decrease if a lower risk free interest rate were used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The unobservable inputs for Level 3 fair value measurements and fair value calculations are developed and determined by the Company’s management with the assistance of a third party valuation specialist. The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s stock warrants that are categorized as Level 3 within the fair value hierarchy: December 31, 2016 Volatility 80.0 % Risk free rate 1.84 % Discount for lack of marketability 20.0 % The following table represents a reconciliation of the Level 3 measurement of the Company’s Primary Warrant (see related discussion in Note 3): Balance, December 31, 2016 $ 7,114 Less: Change in fair value of warrant liability (7,114 ) Balance, June 30, 2017 $ — In addition, in May 2017, upon exercise of the Primary Warrant, the Company issued to Acacia a five-year warrant to purchase 809,400 shares of the Company’s common stock, or 10% Warrant. The fair value of the 10% Warrant under Level 3 measurement is $5,790 (see related discussion in Note 3). The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s 10% Warrant that are categorized as Level 3 within the fair value hierarchy: May 17, 2017 Volatility 70.0 % Risk free rate 1.44 % Discount for lack of marketability 0 %
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, 2014-09 2014-09 2014-09: No. 2016-08, No. 2016-10, No. 2016-12, 2016-20, 2016-08, 2016-10, 2016-12 2016-20 2014-09 In November 2015, the FASB issued ASU No. 2015–17, “Income Taxes: Balance Sheet Classification of Deferred Taxes (Topic 740),” to require that deferred tax liabilities and assets be classified entirely as non-current. In February 2016, the FASB issued ASU No. 2016-02, right-of-use right-of-use In March 2016, the FASB issued ASU No. 2016-09, 2016-09 In August 2016, the FASB issued ASU 2016-15, In May 2017, the FASB issued ASU No. 2017-09, 2017-09

Summary of Significant Accoun16

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Summary of Net Revenues	Net revenues for the three- and six-month Three Months Ended June 30, Six Months Ended June 30, 2017 2016 2017 2016 Media agency revenues $ 3,739 $ 1,938 $ 6,638 $ 3,974 AI platform revenues 348 73 557 113 Total net revenues $ 4,087 $ 2,011 $ 7,195 $ 4,087
Schedule of Other Income (Expense), Net	Other income (expense), net for the three- and six-month periods presented were comprised of the following: Three Months Ended June 30, Six Months Ended June 30, 2017 2016 2017 2016 Interest income (expense), net $ (1,880 ) $ 1 $ (4,234 ) $ 4 Stock warrants issued (5,790 ) — (5,790 ) — Write-off of deferred debt discounts and issuance costs (10,132 ) — (10,132 ) — Gain on fair value change of warrant liability 3,996 — 7,114 — Other 60 3 82 (31 ) Other income (expense), net $ (13,746 ) $ 4 $ (12,960 ) $ (27 )
Computation of Basic and Diluted Net Loss Per Common Share	The following table presents the computation of basic and diluted net loss per common share for the periods presented: Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss per share: Numerator Net loss $ (21,595 ) $ (6,525 ) $ (27,442 ) $ (10,488 ) Accretion of redeemable convertible preferred stock (3,397 ) (794 ) (4,470 ) (1,588 ) Net loss attributable to common stockholders $ (24,992 ) $ (7,319 ) $ (31,912 ) $ (12,076 ) Denominator Weighted-average common shares outstanding 8,666,147 2,424,554 5,679,024 1,862,401 Less: Weighted-average shares subject to repurchase (174,756 ) (140,456 ) (194,645 ) (108,772 ) Denominator for basic and diluted net loss 8,491,391 2,284,098 5,484,379 1,753,629 Basic and diluted net loss per share attributable to common stockholders $ (2.94 ) $ (3.20 ) $ (5.82 ) $ (6.89 )
Effect of Anti-dilutive Securities	Other potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in weighted-average common equivalent shares): Three Months Ended Six Months Ended 2017 2016 2017 2016 Common stock options 2,697,361 682,415 1,682,804 636,112 Warrants to purchase common stock 2,381,530 — 2,165,872 — Shares issuable upon conversion of redeemable convertible preferred stock — 4,828,800 — 4,783,800 Total 5,078,891 5,511,215 3,848,676 5,419,912
Summary of Quantitative Information with Respect to Significant Unobservable Inputs	The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s stock warrants that are categorized as Level 3 within the fair value hierarchy: December 31, 2016 Volatility 80.0 % Risk free rate 1.84 % Discount for lack of marketability 20.0 % The following table summarizes quantitative information with respect to the significant unobservable inputs used for the Company’s 10% Warrant that are categorized as Level 3 within the fair value hierarchy: May 17, 2017 Volatility 70.0 % Risk free rate 1.44 % Discount for lack of marketability 0 %
Reconciliation of Level 3 Measurement of Company's Primary Warrant	The following table represents a reconciliation of the Level 3 measurement of the Company’s Primary Warrant (see related discussion in Note 3): Balance, December 31, 2016 $ 7,114 Less: Change in fair value of warrant liability (7,114 ) Balance, June 30, 2017 $ —

Convertible Notes Payable and17

Convertible Notes Payable and Related Transactions (Tables)	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Reconciliation of Principal Amounts of Acacia Note and the Bridge Loan to Convertible Notes Payable	The following table represents a reconciliation of the principal amounts of the Acacia Note and the Bridge Loan (as described above) to the convertible notes payable included in the Company’s condensed consolidated balance sheets as of: June 30, December 31, First Loan principal, August 15, 2016 $ — $ 10,000 Second Loan principal, November 25, 2016 — 10,000 Debt discounts associated with stock warrants, net — (6,793 ) Debt issuance costs, net — (105 ) Accrued interest — 286 Convertible note payable $ — $ 13,388

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Schedule of Stock-based Compensation Expense	The stock-based compensation expense recognized for the periods presented below was as follows: Three Months Ended Six Months Ended 2017 2016 2017 2016 Stock-based compensation expense by type of award: Restricted stock $ 375 $ 28 $ 451 $ 48 Common stock awards 125 — 125 — Stock options 1,278 1,453 1,327 1,474 Total $ 1,778 $ 1,481 $ 1,903 $ 1,522 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 116 $ 24 $ 155 $ 48 Research and development 92 6 104 12 General and administrative 1,570 1,451 1,644 1,462 Total $ 1,778 $ 1,481 $ 1,903 $ 1,522
Schedule of Restricted Stock Activity	Restricted stock activity for the period presented was as follows: Shares Weighted Unvested at December 31, 2016 208,886 $ 4.80 Granted 52,433 $ 14.79 Forfeited (18,100 ) $ 10.03 Vested (62,313 ) $ 8.16 Unvested at June 30, 2017 180,906 $ 6.01
Schedule of Fair Value Assumptions	The Black-Scholes option-pricing model requires various assumptions, which are noted in the following table: Six Months Ended Expected terms (in years) 5.83 - 6.08 Expected volatility 65% Risk-free interest rate 1.89% - 2.20% Expected dividend yield —
Schedule of Stock Option Activity	The Company’s stock option activity for the period presented was as follows: Weighted-Average Options Exercise Remaining Aggregate Outstanding at December 31, 2016 680,434 $ 2.27 8.49 years $ 3,031 Options Granted 3,801,158 $ 15.00 Options Exercised (1,580 ) $ 1.93 Options Forfeited / Cancelled (48,905 ) $ 2.88 Outstanding at June 30, 2017 4,431,107 $ 13.17 8.33 years $ 5,972 Exercisable at June 30, 2017 350,716

Description of Business and B19

Description of Business and Basis of Presentation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	May 17, 2017	May 31, 2017	Mar. 31, 2017	Aug. 31, 2016	Jun. 30, 2017	May 16, 2017	Dec. 31, 2016
Organization [Line Items]
Common stock issued					12,335,265
Proceeds from issuance of common stock					$ 33,199
Net book value							$ 23,350
Cash proceeds from exercise of warrants					$ 29,263
Warrants to purchase common stock					1,277,157
Warrants maturity period					4 years
Bridge Loan [Member]
Organization [Line Items]
Accrued interest	$ 45
Warrants to purchase common stock	313,446					240,000
Fully diluted shares outstanding percentage	1.50%
Shares converted to common stock	590,717
Series B Redeemable Convertible Preferred Stock [Member]
Organization [Line Items]
Liquidation preference value	$ 18,668
Net book value	$ 18,463						17,897
Shares converted to common stock	2,309,135				2,309,135
Series A Redeemable Convertible Preferred Stock [Member]
Organization [Line Items]
Liquidation preference value	$ 8,598
Net book value	$ 6,272						$ 5,453
Shares converted to common stock	2,922,798				2,922,798
Initial Public Offering [Member]
Organization [Line Items]
Common stock issued	2,500,000				2,500,000
Common stock price per share	$ 15
Proceeds from issuance of common stock	$ 32,534
Underwriting discounts, commissions and offering costs	$ 4,966
Warrants to purchase common stock	809,400		809,400
Warrants maturity period	5 years		5 years
Warrant exercise price			$ 13.6088
Convertible Notes Payable [Member] | Initial Public Offering [Member]
Organization [Line Items]
Warrants to purchase common stock	154,311		154,311
Maximum [Member] | Initial Public Offering [Member]
Organization [Line Items]
Warrants to purchase common stock	51,437		51,437
Acacia [Member]
Organization [Line Items]
Common stock issued			120,000
Acacia [Member] | Bridge Loan [Member]
Organization [Line Items]
Common stock issued	90,000
Debt instrument principal balance	$ 8,000
Borrowing under line of credit	$ 4,000
Warrants to purchase common stock	120,000
Fully diluted shares outstanding percentage	0.75%
Warrants maturity period	10 years
Acacia [Member] | Initial Public Offering [Member]
Organization [Line Items]
Warrants to purchase common stock	809,400	809,400
Warrants maturity period	5 years	5 years
Warrant exercise price	$ 13.6088
Acacia [Member] | Convertible Notes Payable [Member]
Organization [Line Items]
Shares converted to common stock	1,523,746			1,523,746	1,523,746
Debt instrument principal balance	$ 20,000			$ 20,000
Accrued interest	$ 737
Warrants maturity period				5 years
Warrant exercise price				$ 13.6088
Acacia [Member] | Primary Warrant [Member]
Organization [Line Items]
Issuance of stock due to warrants exercise	2,150,335		2,150,335		2,150,335
Cash proceeds from exercise of warrants	$ 29,263		$ 29,263
Acacia [Member] | Maximum [Member] | Bridge Loan [Member]
Organization [Line Items]
Warrant exercise price	$ 13.6088
Acacia [Member] | Maximum [Member] | Convertible Notes Payable [Member]
Organization [Line Items]
Warrant exercise price			$ 13.6088
Acacia [Member] | Maximum [Member] | Primary Warrant [Member]
Organization [Line Items]
Warrant exercise price			$ 13.7323

Summary of Significant Accoun20

Summary of Significant Accounting Policies - Summary of Net Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Total net revenues	$ 4,087	$ 2,011	$ 7,195	$ 4,087
Media Agency Revenues [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Total net revenues	3,739	1,938	6,638	3,974
AI Platform Revenues [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Total net revenues	$ 348	$ 73	$ 557	$ 113

Summary of Significant Accoun21

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	May 17, 2017	May 31, 2017	Mar. 31, 2017	Aug. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross media placements					$ 31,243	$ 16,962	$ 57,485	$ 35,037
Amortization of deferred debt discounts and issuance costs							$ 3,740
Warrants to purchase common stock					1,277,157		1,277,157
Warrants maturity period							4 years
Fair market value of warrants									$ 7,114
Initial Public Offering [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Warrants to purchase common stock	809,400		809,400
Warrants maturity period	5 years		5 years
Percentage of warrant exercise	10.00%		10.00%
Acacia [Member] | Initial Public Offering [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Warrants to purchase common stock	809,400	809,400
Warrants maturity period	5 years	5 years
Percentage of warrant exercise	10.00%	10.00%
Fair market value of warrants	$ 5,790	$ 5,790
Convertible Notes Payable [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Amortization of deferred debt discounts and issuance costs					$ 1,686		$ 3,740
Convertible Notes Payable [Member] | Initial Public Offering [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Warrants to purchase common stock	154,311		154,311
Convertible Notes Payable [Member] | Acacia [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Warrants maturity period				5 years
Billed Revenues [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross media placements					28,784	14,585	48,207	29,608
Netted Against Billings [Member]
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]
Gross media placements					$ 25,045	$ 12,647	$ 41,569	$ 25,634

Summary of Significant Accoun22

Summary of Significant Accounting Policies - Schedule of Other Income (Expense), Net (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Other Income and Expenses [Abstract]
Interest income (expense), net	$ (1,880)	$ 1	$ (4,234)	$ 4
Stock warrants issued	(5,790)		(5,790)
Write-off of deferred debt discounts and issuance costs	(10,132)		(10,132)
Gain on fair value change of warrant liability	3,996		7,114
Other	60	3	82	(31)
Other income (expense), net	$ (13,746)	$ 4	$ (12,960)	$ (27)

Summary of Significant Accoun23

Summary of Significant Accounting Policies - Computation of Basic and Diluted Net Loss Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Numerator
Net loss	$ (21,595)	$ (6,525)	$ (27,442)	$ (10,488)
Accretion of redeemable convertible preferred stock	(3,397)	(794)	(4,470)	(1,588)
Net loss attributable to common stockholders	$ (24,992)	$ (7,319)	$ (31,912)	$ (12,076)
Denominator
Weighted-average common shares outstanding	8,666,147	2,424,554	5,679,024	1,862,401
Less: Weighted-average shares subject to repurchase	(174,756)	(140,456)	(194,645)	(108,772)
Denominator for basic and diluted net loss per share attributable to common stockholders	8,491,391	2,284,098	5,484,379	1,753,629
Basic and diluted net loss per share attributable to common stockholders	$ (2.94)	$ (3.20)	$ (5.82)	$ (6.89)

Summary of Significant Accoun24

Summary of Significant Accounting Policies - Effect of Anti-dilutive Securities (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	5,078,891	5,511,215	3,848,676	5,419,912
Redeemable Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities		4,828,800		4,783,800
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	2,697,361	682,415	1,682,804	636,112
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	2,381,530		2,165,872

Summary of Significant Accoun25

Summary of Significant Accounting Policies - Summary of Quantitative Information with Respect to Significant Unobservable Inputs (Detail)	May 17, 2017	Dec. 31, 2017
Fair Value Inputs, Quantitative Information [Abstract]
Volatility	70.00%	80.00%
Risk free rate	1.44%	1.84%
Discount for lack of marketability	0.00%	20.00%

Summary of Significant Accoun26

Summary of Significant Accounting Policies - Reconciliation of Level 3 Measurement of Company's Primary Warrant (Detail) - Warrant [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2017USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning, Balance	$ 7,114
Less: Change in fair value of warrant liability	$ (7,114)

Convertible Notes Payable and27

Convertible Notes Payable and Related Transactions - Additional Information (Detail) - USD ($)	May 17, 2017	Apr. 30, 2017	Mar. 31, 2017	May 31, 2017	Mar. 31, 2017	Aug. 31, 2016	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2017	May 16, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Change in fair value of warrants							$ (3,996,000)		$ (7,114,000)
Cash proceeds from exercise of warrants									$ 29,263,000
Warrants to purchase common stock							1,277,157		1,277,157
Warrants maturity period									4 years
Fair market value of warrants											$ 7,114,000
Common stock issued									12,335,265
Debt discounts associated with stock warrants											$ 6,793,000
Issuance of warrants									$ 8,658,000
Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrant exercise price			$ 13.6088		$ 13.6088			$ 13.6088
Warrants to purchase common stock	809,400		809,400		809,400			809,400
Warrants maturity period	5 years				5 years
Percentage of warrant exercise	10.00%				10.00%
Warrant vesting period									Fifty percent of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant and the remaining fifty percent of the shares vesting on the first anniversary of the issuance date of the 10% Warrant.
Common stock issued	2,500,000								2,500,000
Issuance of common stock									$ 32,534,000
Vested Upon Issuance [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrant vesting percentage	50.00%				50.00%
Convertible Notes Payable [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrants to purchase common stock	154,311		154,311		154,311			154,311
Bridge Loan [Member]
Debt Instrument [Line Items]
Borrowing under line of credit					$ 2,000,000
Common stock issued					90,000
Shares converted to common stock									590,717
Issuance of common stock									$ 3,666,000
Note Purchase Agreement [Member]
Debt Instrument [Line Items]
Common stock issued					120,000
VLOC, LLC [Member]
Debt Instrument [Line Items]
Warrants to purchase common stock							313,446		313,446
VLOC, LLC [Member] | Bridge Loan [Member]
Debt Instrument [Line Items]
Warrant exercise price	$ 13.6088						$ 13.6088		$ 13.6088
Warrants to purchase common stock	313,446						313,446		313,446
Warrants maturity period	10 years								10 years
VLOC, LLC [Member] | Note Purchase Agreement [Member]
Debt Instrument [Line Items]
Warrants maturity period								10 years
Common stock issued					120,000
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Bridge Loan [Member]
Debt Instrument [Line Items]
Debt instrument principal balance	$ 8,000,000
Accrued interest	$ 45,000
Conversion price per share	$ 13.6088
Warrants to purchase common stock	313,446									240,000
Borrowing under line of credit	$ 4,000,000
Additional common stock issued	180,000
Fully diluted shares outstanding percentage	1.50%
Warrants issued									$ 0
Shares converted to common stock	590,717
Debt discounts associated with stock warrants	$ 2,915,000
Issuance of common stock	1,100,000
Issuance of warrants	$ 1,770,000
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Chad Steelberg and Ryan Steelberg [Member]
Debt Instrument [Line Items]
Ownership percentage	50.00%								50.00%
Primary Warrant [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Gain on exercise of warrants charged to other Income (expense)							$ 3,996,000
Maximum [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrants to purchase common stock	51,437		51,437		51,437			51,437
Maximum [Member] | VLOC, LLC [Member] | Note Purchase Agreement [Member]
Debt Instrument [Line Items]
Warrant exercise price	$ 13.6088
Acacia [Member]
Debt Instrument [Line Items]
Common stock issued					120,000
Acacia [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrant exercise price	$ 13.6088
Warrants to purchase common stock	809,400			809,400
Warrants maturity period	5 years			5 years
Percentage of warrant exercise	10.00%			10.00%
Warrant vesting period									Fifty percent of the shares under the 10% Warrant vested upon its issuance and the remaining half will vest in May 2018.
Fair market value of warrants	$ 5,790,000			$ 5,790,000
Acacia [Member] | Vested Upon Issuance [Member] | Initial Public Offering [Member]
Debt Instrument [Line Items]
Warrant vesting percentage	50.00%
Acacia [Member] | Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Convertible note payable, public offering gross proceeds for automatic conversion					$ 15,000,000
Warrant exercise price						$ 13.6088
Debt instrument principal balance	$ 20,000,000					$ 20,000,000
Accrued interest	$ 737,000
Shares converted to common stock	1,523,746					1,523,746			1,523,746
Conversion price per share	$ 13.6088
Write off of unamortized balance of debt discounts associated with stock warrants	$ 4,347,000
Warrants maturity period						5 years
Acacia [Member] | Bridge Loan [Member]
Debt Instrument [Line Items]
Debt instrument principal balance			$ 8,000,000		$ 8,000,000			$ 8,000,000
Conversion price per share			$ 13.6088		$ 13.6088			$ 13.6088
Warrants maturity period		10 years
Line of credit maximum borrowing capacity			$ 8,000,000		$ 8,000,000			$ 8,000,000
Line of credit, interest rate					8.00%
Line of credit, borrowing description								The Company borrowed the initial $2,000 installment under the Bridge Loan in March 2017, and borrowed the second $2,000 installment in April 2017. Prior to the completion of the IPO, the Lenders exercised their options to advance the remaining $4,000 remaining available under the Bridge Loan.
Borrowing under line of credit		$ 2,000,000			$ 2,000,000			$ 4,000,000
Common stock issued								180,000
Shares converted to common stock			590,717
Acacia [Member] | VLOC, LLC [Member] | Note Purchase Agreement [Member]
Debt Instrument [Line Items]
Line of credit maximum borrowing capacity			$ 8,000,000		$ 8,000,000			$ 8,000,000
Line of credit, interest rate					8.00%
Line of credit, maturity date					Nov. 25, 2017
Line of credit, borrowing description									The Company drew down the initial $2,000 installment under the Bridge Loan upon the execution of the Note Purchase Agreement. In April 2017, the Company borrowed an additional $2,000 under the Bridge Loan. In May 2017, the Lenders funded the remaining undrawn amounts of $4,000 under the Bridge Loan, which increased the outstanding principal balance of the Bridge Loan to $8,000.
Acacia [Member] | VLOC, LLC [Member] | Note Purchase Agreement [Member] | Bridge Loan [Member]
Debt Instrument [Line Items]
Debt instrument principal balance				8,000,000
Borrowing under line of credit		$ 2,000,000		$ 4,000,000	$ 2,000,000
Acacia [Member] | Primary Warrant [Member]
Debt Instrument [Line Items]
Issuance of stock due to warrants exercise	2,150,335		2,150,335		2,150,335		2,150,335	2,150,335	2,150,335
Cash proceeds from exercise of warrants	$ 29,263,000				$ 29,263,000
Acacia [Member] | Primary Warrant [Member] | Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Change in fair value of warrants					$ 3,118,000
Acacia [Member] | Maximum [Member] | Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Warrant exercise price			$ 13.6088		$ 13.6088			$ 13.6088
Acacia [Member] | Maximum [Member] | Primary Warrant [Member]
Debt Instrument [Line Items]
Warrant exercise price			$ 13.7323		$ 13.7323			$ 13.7323
Conversion price per share	$ 13.6088

Convertible Notes Payable and28

Convertible Notes Payable and Related Transactions - Reconciliation of Principal Amounts of Acacia Note and the Bridge Loan to Convertible Notes Payable (Detail) $ in Thousands	Dec. 31, 2016USD ($)
Debt Instrument [Line Items]
Debt discounts associated with stock warrants, net	$ (6,793)
Debt issuance costs, net	(105)
Accrued interest	286
Convertible note payable	13,388
First Loans [Member]
Debt Instrument [Line Items]
Borrowings	10,000
Second Loans [Member]
Debt Instrument [Line Items]
Borrowings	$ 10,000

Redeemable Convertible Prefer29

Redeemable Convertible Preferred Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	May 17, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2017	May 31, 2017	Apr. 30, 2017	Dec. 31, 2016
Class of Stock [Line Items]
Net book value							$ 23,350
Preferred Stock, authorized					1,000,000	11,500,000
Preferred Stock, par value						$ 0.001
Series B Redeemable Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Liquidation preference value	$ 18,668
Net book value	$ 18,463						$ 17,897
Shares converted to common stock	2,309,135			2,309,135
Change in liquidation preference and net book value	$ 205
Debt beneficial conversion feature			$ 226
Debt amortization of discount		$ 10		$ 67
Write-off of unamortized portion of beneficial conversion feature				$ 159
Preferred Stock, authorized		0		0			3,092,781
Preferred Stock, par value		$ 0.001		$ 0.001			$ 0.001
Series A Redeemable Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Liquidation preference value	8,598
Net book value	$ 6,272						$ 5,453
Shares converted to common stock	2,922,798			2,922,798
Change in liquidation preference and net book value	$ 2,326
Debt beneficial conversion feature			$ 328
Debt amortization of discount		$ 14		$ 96
Write-off of unamortized portion of beneficial conversion feature				$ 232
Preferred Stock, authorized		0		0			5,666,667
Preferred Stock, par value		$ 0.001		$ 0.001			$ 0.001

Stockholders' Equity (Deficit30

Stockholders' Equity (Deficit) - Additional Information (Detail)

May 17, 2017USD ($)$ / sharesshares

Apr. 30, 2017USD ($)shares

Apr. 20, 2017

Mar. 31, 2017USD ($)$ / sharesshares

Jan. 04, 2017USD ($)shares

May 31, 2017USD ($)$ / sharesshares

Apr. 30, 2017shares

Mar. 31, 2017USD ($)$ / sharesshares

Nov. 30, 2016USD ($)$ / sharesshares

Aug. 31, 2016$ / sharesshares

Jun. 30, 2017USD ($)$ / sharesshares

Mar. 31, 2017USD ($)$ / sharesshares

Jun. 30, 2016USD ($)

Jun. 30, 2017USD ($)$ / sharesshares

Jun. 30, 2016USD ($)

May 16, 2017shares

Dec. 31, 2016$ / sharesshares

Class of Stock [Line Items]

Reverse stock split ratio

0.6

Stockholders' equity, reverse stock split

0.6-for-1.0

Common stock, shares authorized

38,500,000

75,000,000

38,500,000

75,000,000

75,000,000

38,500,000

Common stock, par value | $ / shares

$ 0.001

$ 0.001

$ 0.001

$ 0.001

Common stock shares issued

12,335,265

Stock issued during period, shares, exercise of stock options

1,580

Warrants maturity period

4 years

Issuance of warrants to purchase common stock | $

$ 8,658,000

Outstanding warrants

1,277,157

1,277,157

Share based lump sum payment | $

$ 350,000

Repurchase of common stock

7,500

Payment of buyback of common stock | $

$ 56,000

$ 56,000

Stock-based compensation expense | $

$ 1,778,000

$ 1,481,000

$ 1,903,000

$ 1,522,000

Expected forfeitures rate

10.00%

Chief Executive Officer [Member]

Class of Stock [Line Items]

Common stock shares issued

10,121

Common stock granted

10,121

Bridge Loan [Member]

Class of Stock [Line Items]

Common stock shares issued

90,000

Borrowing under line of credit | $

$ 2,000,000

Shares converted to common stock

590,717

First Loans [Member]

Class of Stock [Line Items]

Issuance of warrants to purchase common stock | $

$ 700,000

Second Loans [Member]

Class of Stock [Line Items]

Warrants maturity period

4 years

Issuance of warrants to purchase common stock | $

$ 700,000

Issuance of warrants to purchase common stock

2

Acacia [Member]

Class of Stock [Line Items]

Common stock shares issued

120,000

Acacia [Member] | Bridge Loan [Member]

Class of Stock [Line Items]

Common stock shares issued

180,000

Borrowing under line of credit | $

$ 2,000,000

$ 2,000,000

$ 4,000,000

Shares converted to common stock

590,717

Warrants maturity period

10 years

Acacia [Member] | Convertible Notes Payable [Member]

Class of Stock [Line Items]

Shares converted to common stock

1,523,746

1,523,746

1,523,746

Warrants maturity period

5 years

Warrant exercise price | $ / shares

$ 13.6088

Acacia [Member] | First Loans [Member]

Class of Stock [Line Items]

Warrants maturity period

4 years

Issuance of warrants to purchase common stock | $

$ 700,000

Acacia [Member] | Second Loans [Member]

Class of Stock [Line Items]

Warrants maturity period

4 years

Issuance of warrants to purchase common stock

700,000

1,277,157

Outstanding warrants

1,277,157

1,277,157

Acacia [Member] | Primary Warrant [Member]

Class of Stock [Line Items]

Issuance of stock due to warrants exercise

2,150,335

2,150,335

2,150,335

2,150,335

2,150,335

2,150,335

VLOC, LLC [Member] | Bridge Loan [Member]

Class of Stock [Line Items]

Common stock shares issued

90,000

Borrowing under line of credit | $

$ 4,000,000

Series B Redeemable Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Shares converted to common stock

2,309,135

2,309,135

Series A Redeemable Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Shares converted to common stock

2,922,798

2,922,798

Maximum [Member] | First Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.7323

$ 13.7323

Maximum [Member] | Second Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.7323

Maximum [Member] | Acacia [Member] | Convertible Notes Payable [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.6088

$ 13.6088

$ 13.6088

Maximum [Member] | Acacia [Member] | First Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

13.7323

13.7323

Maximum [Member] | Acacia [Member] | Second Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

13.7323

Maximum [Member] | Acacia [Member] | Primary Warrant [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

13.7323

13.7323

13.7323

Minimum [Member] | First Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

8.0833

8.0833

Minimum [Member] | Second Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

8.0833

Minimum [Member] | Acacia [Member] | First Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 8.0833

$ 8.0833

Minimum [Member] | Acacia [Member] | Second Loans [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 8.0833

Minimum [Member] | Acacia [Member] | Primary Warrant [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

13.3028

$ 13.3028

13.3028

Initial Public Offering [Member]

Class of Stock [Line Items]

Common stock shares issued

2,500,000

2,500,000

Warrants maturity period

5 years

5 years

Warrant exercise price | $ / shares

$ 13.6088

$ 13.6088

$ 13.6088

Outstanding warrants

809,400

809,400

809,400

809,400

IPO completion date

May 17, 2017

Percentage of warrant exercise

10.00%

10.00%

Initial Public Offering [Member] | Vested Upon Issuance [Member]

Class of Stock [Line Items]

Warrant vesting percentage

50.00%

50.00%

Initial Public Offering [Member] | Vest in May 2018 [Member]

Class of Stock [Line Items]

Warrant vesting percentage

50.00%

Initial Public Offering [Member] | Convertible Notes Payable [Member]

Class of Stock [Line Items]

Outstanding warrants

154,311

154,311

154,311

154,311

Initial Public Offering [Member] | Amended Primary Warrant [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.6088

$ 13.6088

$ 13.6088

Initial Public Offering [Member] | Acacia [Member]

Class of Stock [Line Items]

Warrants maturity period

5 years

5 years

Warrant exercise price | $ / shares

$ 13.6088

Outstanding warrants

809,400

809,400

Percentage of warrant exercise

10.00%

10.00%

Initial Public Offering [Member] | Acacia [Member] | Vested Upon Issuance [Member]

Class of Stock [Line Items]

Warrant vesting percentage

50.00%

Initial Public Offering [Member] | Acacia [Member] | Amended Primary Warrant [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.6088

$ 13.6088

$ 13.6088

Initial Public Offering [Member] | Maximum [Member]

Class of Stock [Line Items]

Outstanding warrants

51,437

51,437

51,437

51,437

Consultants [Member]

Class of Stock [Line Items]

Issuance of restricted stock, shares

17,333

VLOC, LLC [Member]

Class of Stock [Line Items]

Outstanding warrants

313,446

313,446

VLOC, LLC [Member] | Bridge Loan [Member]

Class of Stock [Line Items]

Warrants maturity period

10 years

10 years

Warrant exercise price | $ / shares

$ 13.6088

$ 13.6088

$ 13.6088

Outstanding warrants

313,446

313,446

313,446

2014 Stock Option/Stock Issuance Plan [Member]

Class of Stock [Line Items]

Issuance of restricted stock, shares

9,500

Stock issued during period, shares, exercise of stock options

1,580

Common stock reserved for future issuance

900,000

900,000

Increase in common stock reserved for future issuance

4,450,585

4,450,585

Options Granted

3,801,158

Options exercise price | $ / shares

$ 15

Options exercise price | $ / shares

$ 1.93

Unrecognized compensation expense related to stock options | $

$ 33,114,000

$ 33,114,000

2014 Stock Option/Stock Issuance Plan [Member] | Employees And Directors [Member]

Class of Stock [Line Items]

Options Granted

666,702

Options exercise price | $ / shares

$ 15

Vesting period

4 years

2017 Stock Incentive Plan [Member]

Class of Stock [Line Items]

Common stock reserved for future issuance

2,000,000

2,000,000

Annual shares increase for future issuance by percentage under employee stock purchase plans

3.00%

2017 Stock Incentive Plan [Member] | Maximum [Member]

Class of Stock [Line Items]

Increase in common stock reserved for future issuance

750,000

750,000

Employee Stock Purchase Plan [Member]

Class of Stock [Line Items]

Common stock reserved for future issuance

1,000,000

1,000,000

Annual shares increase for future issuance by percentage under employee stock purchase plans

1.00%

Maximum number of shares per employee in each purchase

1,000

Common stock granted

0

Employee Stock Purchase Plan [Member] | Maximum [Member]

Class of Stock [Line Items]

Increase in common stock reserved for future issuance

250,000

250,000

Employee Stock Purchase Plan [Member] | Minimum [Member]

Class of Stock [Line Items]

Percentage of purchase price of common stock fair value

85.00%

Note Purchase Agreement [Member]

Class of Stock [Line Items]

Common stock shares issued

120,000

Note Purchase Agreement [Member] | VLOC, LLC [Member]

Class of Stock [Line Items]

Common stock shares issued

120,000

Warrants maturity period

10 years

Note Purchase Agreement [Member] | VLOC, LLC [Member] | Bridge Loan [Member]

Class of Stock [Line Items]

Borrowing under line of credit | $

$ 4,000,000

Shares converted to common stock

590,717

Issuance of warrants to purchase common stock | $

$ 1,770,000

Outstanding warrants

313,446

240,000

Note Purchase Agreement [Member] | VLOC, LLC [Member] | Acacia [Member] | Bridge Loan [Member]

Class of Stock [Line Items]

Borrowing under line of credit | $

$ 2,000,000

$ 4,000,000

$ 2,000,000

Note Purchase Agreement [Member] | VLOC, LLC [Member] | Maximum [Member]

Class of Stock [Line Items]

Warrant exercise price | $ / shares

$ 13.6088

Restricted Stock [Member]

Class of Stock [Line Items]

Stock-based compensation expense | $

$ 375,000

28,000

$ 451,000

48,000

Restricted Stock [Member] | 2014 Stock Option/Stock Issuance Plan [Member]

Class of Stock [Line Items]

Vesting period

4 years

Restricted stock units granted

52,433

Unrecognized cost of share-based compensation awards | $

1,088,000

$ 1,088,000

Cost of share-based compensation awards, recognition period

2 years 8 months 12 days

Stock Options [Member]

Class of Stock [Line Items]

Stock-based compensation expense | $

$ 1,278,000

$ 1,453,000

$ 1,327,000

$ 1,474,000

Stock Options [Member] | 2014 Stock Option/Stock Issuance Plan [Member]

Class of Stock [Line Items]

Vesting period

4 years

Cost of share-based compensation awards, recognition period

2 years 3 months 19 days

Expiration period

10 years

Restricted Stock Units [Member] | 2017 Stock Incentive Plan [Member] | Directors [Member]

Class of Stock [Line Items]

Common stock reserved for future issuance

1,964,424

1,964,424

Restricted stock units granted

35,576

Options exercise price | $ / shares

$ 14.76

Time-based Stock Option [Member] | Chad Steelberg and Ryan Steelberg [Member]

Class of Stock [Line Items]

Options Granted

2,089,638

2,089,638

Options exercise price | $ / shares

$ 15

Vesting period

3 years

3 years

Annual shares increase for future issuance by percentage under employee stock purchase plans

5.00%

Performance- based Stock Option [Member] | Chad Steelberg and Ryan Steelberg [Member]

Class of Stock [Line Items]

Options Granted

1,044,818

1,044,818

Options exercise price | $ / shares

$ 15

Vesting period

5 years

5 years

Vesting rights description

The performance-based stock option would vest upon the earlier of (a) the first date on which the market capitalization of the Company's common stock equals or exceeds $400,000 over five consecutive business days, or (b) five years after the IPO

The performance-based stock option would vest upon the earlier of (a) the first date on which the market capitalization of the Company's common stock equals or exceeds $400,000 over five consecutive business days, or (b) five years after the IPO.

Vesting rights, market capitalization | $

$ 400,000,000

$ 400,000,000

$ 400,000,000

$ 400,000,000

$ 400,000,000

Vesting rights, consecutive trading days

5 days

5 days

Annual shares increase for future issuance by percentage under employee stock purchase plans

2.50%

Stockholders' Equity (Deficit31

Stockholders' Equity (Deficit) - Schedule of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 1,778	$ 1,481	$ 1,903	$ 1,522
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	116	24	155	48
Research and Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	92	6	104	12
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	1,570	1,451	1,644	1,462
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	375	28	451	48
Common Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	125		125
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 1,278	$ 1,453	$ 1,327	$ 1,474

Stockholders' Equity (Deficit32

Stockholders' Equity (Deficit) - Schedule of Restricted Stock Activity (Detail) - 2014 Stock Option/Stock Issuance Plan [Member] - Restricted Stock [Member]	6 Months Ended
	Jun. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Unvested, Beginning Balance | shares	208,886
Shares, Granted | shares	52,433
Shares, Forfeited | shares	(18,100)
Shares, Vested | shares	(62,313)
Shares, Unvested, Ending Balance | shares	180,906
Weighted Average Grant Date Fair Value, Unvested, Beginning Balance | $ / shares	$ 4.80
Weighted Average Grant Date Fair Value, Granted | $ / shares	14.79
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	10.03
Weighted Average Grant Date Fair Value, Vested | $ / shares	8.16
Weighted Average Grant Date Fair Value, Unvested, Ending Balance | $ / shares	$ 6.01

Stockholders' Equity (Deficit33

Stockholders' Equity (Deficit) - Schedule of Fair Value Assumptions (Detail)	6 Months Ended
	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	65.00%
Risk-free interest rate, minimum	1.89%
Risk-free interest rate, maximum	2.20%
Expected dividend yield	0.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected terms (in years)	5 years 9 months 29 days
Expected dividend yield	0.00%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected terms (in years)	6 years 29 days
Expected dividend yield	0.00%

Stockholders' Equity (Deficit34

Stockholders' Equity (Deficit) - Schedule of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Exercised	(1,580)
2014 Stock Option/Stock Issuance Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, Outstanding, Beginning Balance	680,434
Options Granted	3,801,158
Options Exercised	(1,580)
Options Forfeited / Cancelled	(48,905)
Options, Outstanding, Ending Balance	4,431,107	680,434
Options, Exercisable at June 30, 2017	350,716
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 2.27
Weighted-Average Exercise Price, Options Granted | $ / shares	15
Weighted-Average Exercise Price, Options Exercised | $ / shares	1.93
Weighted-Average Exercise Price, Options Forfeited / Cancelled | $ / shares	2.88
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	$ 13.17	$ 2.27
Weighted-Average Remaining Contractual Term, Outstanding	8 years 3 months 29 days	8 years 5 months 27 days
Weighted-Average Aggregate Intrinsic Value | $	$ 5,972	$ 3,031

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	May 17, 2017USD ($)$ / sharesshares	Apr. 30, 2017USD ($)	Mar. 31, 2017USD ($)$ / sharesshares	May 31, 2017USD ($)shares	Mar. 31, 2017USD ($)$ / sharesshares	Nov. 30, 2016USD ($)$ / sharesshares	Aug. 31, 2016USD ($)$ / sharesshares	Jun. 30, 2017USD ($)$ / sharesshares	Mar. 31, 2017USD ($)$ / sharesshares	Jun. 30, 2016USD ($)	Jun. 30, 2017USD ($)Option$ / sharesshares	Jun. 30, 2016USD ($)	May 16, 2017shares	Dec. 31, 2016USD ($)
Related Party Transaction [Line Items]
Warrants maturity period											4 years
Cash proceeds from exercise of warrants											$ 29,263,000
Issuance of warrants to purchase common stock											$ 8,658,000
Warrant issued to purchase common stock | shares								1,277,157			1,277,157
Common stock issued | shares											12,335,265
Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.6088		$ 13.6088				$ 13.6088
Warrants maturity period	5 years				5 years
Warrant issued to purchase common stock | shares	809,400		809,400		809,400				809,400
Percentage of warrant exercise	10.00%				10.00%
Warrant vesting period											Fifty percent of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant and the remaining fifty percent of the shares vesting on the first anniversary of the issuance date of the 10% Warrant.
Common stock issued | shares	2,500,000										2,500,000
Initial Public Offering [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant issued to purchase common stock | shares	51,437		51,437		51,437				51,437
Vested Upon Issuance [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant vesting percentage	50.00%				50.00%
Convertible Notes Payable [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant issued to purchase common stock | shares	154,311		154,311		154,311				154,311
First Loans [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance														$ 10,000,000
Issuance of warrants to purchase common stock											$ 700,000
First Loans [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares								$ 8.0833			$ 8.0833
First Loans [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares								13.7323			$ 13.7323
Second Loans [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance														10,000,000
Warrants maturity period						4 years
Issuance of warrants to purchase common stock						$ 700,000
Number of warrants issued | shares						2
Second Loans [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares						$ 8.0833
Second Loans [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares						$ 13.7323
Bridge Loan [Member]
Related Party Transaction [Line Items]
Borrowing under line of credit					$ 2,000,000
Shares converted to common stock | shares											590,717
Common stock issued | shares					90,000
Amended Primary Warrant [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.6088		$ 13.6088				$ 13.6088
Acacia [Member]
Related Party Transaction [Line Items]
Common stock issued | shares					120,000
Acacia [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares	$ 13.6088
Warrants maturity period	5 years			5 years
Warrant issued to purchase common stock | shares	809,400			809,400
Percentage of warrant exercise	10.00%			10.00%
Warrant vesting period											Fifty percent of the shares under the 10% Warrant vested upon its issuance and the remaining half will vest in May 2018.
Acacia [Member] | Vested Upon Issuance [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant vesting percentage	50.00%
Acacia [Member] | Convertible Notes Payable [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance	$ 20,000,000						$ 20,000,000
Debt instrument interest rate							6.00%
Shares converted to common stock | shares	1,523,746						1,523,746				1,523,746
Warrant exercise price | $ / shares							$ 13.6088
Warrants maturity period							5 years
Conversion price per share | $ / shares	$ 13.6088
Acacia [Member] | Convertible Notes Payable [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.6088		$ 13.6088				$ 13.6088
Acacia [Member] | First Loans [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance							$ 10,000,000
Warrants maturity period											4 years
Issuance of warrants to purchase common stock											$ 700,000
Acacia [Member] | First Loans [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares								8.0833			$ 8.0833
Acacia [Member] | First Loans [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares								$ 13.7323			$ 13.7323
Acacia [Member] | Second Loans [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance							$ 10,000,000
Warrants maturity period						4 years
Number of warrants issued | shares						700,000					1,277,157
Warrant issued to purchase common stock | shares								1,277,157			1,277,157
Acacia [Member] | Second Loans [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares						$ 8.0833
Acacia [Member] | Second Loans [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares						$ 13.7323
Acacia [Member] | Bridge Loan [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance			$ 8,000,000		$ 8,000,000				$ 8,000,000
Warrants maturity period		10 years
Line of credit maximum borrowing capacity			$ 8,000,000		$ 8,000,000				8,000,000
Line of credit, interest rate					8.00%
Borrowing under line of credit		$ 2,000,000			$ 2,000,000				$ 4,000,000
Shares converted to common stock | shares			590,717
Conversion price per share | $ / shares			$ 13.6088		$ 13.6088				$ 13.6088
Line of credit, borrowing description									The Company borrowed the initial $2,000 installment under the Bridge Loan in March 2017, and borrowed the second $2,000 installment in April 2017. Prior to the completion of the IPO, the Lenders exercised their options to advance the remaining $4,000 remaining available under the Bridge Loan.
Common stock issued | shares									180,000
Acacia [Member] | Primary Warrant [Member]
Related Party Transaction [Line Items]
Issuance of stock due to warrants exercise | shares	2,150,335		2,150,335		2,150,335			2,150,335	2,150,335		2,150,335
Cash proceeds from exercise of warrants	$ 29,263,000				$ 29,263,000
Acacia [Member] | Primary Warrant [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.3028		$ 13.3028				$ 13.3028
Acacia [Member] | Primary Warrant [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.7323		$ 13.7323				$ 13.7323
Warrants exercise price value			$ 50,000,000		$ 50,000,000				$ 50,000,000
Conversion price per share | $ / shares	$ 13.6088
Acacia [Member] | Amended Primary Warrant [Member] | Initial Public Offering [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares			$ 13.6088		$ 13.6088				$ 13.6088
Note Purchase Agreement [Member]
Related Party Transaction [Line Items]
Common stock issued | shares					120,000
VLOC, LLC [Member]
Related Party Transaction [Line Items]
Warrant issued to purchase common stock | shares								313,446			313,446
VLOC, LLC [Member] | Bridge Loan [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares	$ 13.6088							$ 13.6088			$ 13.6088
Warrants maturity period	10 years										10 years
Warrant issued to purchase common stock | shares	313,446							313,446			313,446
VLOC, LLC [Member] | Note Purchase Agreement [Member]
Related Party Transaction [Line Items]
Warrants maturity period									10 years
Common stock issued | shares					120,000
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Warrant exercise price | $ / shares	$ 13.6088
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Bridge Loan [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance	$ 8,000,000
Issuance of warrants to purchase common stock	$ 1,770,000
Warrant issued to purchase common stock | shares	313,446												240,000
Borrowing under line of credit	$ 4,000,000
Shares converted to common stock | shares	590,717
Conversion price per share | $ / shares	$ 13.6088
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Chad Steelberg and Ryan Steelberg [Member]
Related Party Transaction [Line Items]
Ownership percentage	50.00%										50.00%
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Acacia [Member]
Related Party Transaction [Line Items]
Line of credit maximum borrowing capacity			$ 8,000,000		$ 8,000,000				$ 8,000,000
Line of credit, interest rate					8.00%
Line of credit, borrowing description											The Company drew down the initial $2,000 installment under the Bridge Loan upon the execution of the Note Purchase Agreement. In April 2017, the Company borrowed an additional $2,000 under the Bridge Loan. In May 2017, the Lenders funded the remaining undrawn amounts of $4,000 under the Bridge Loan, which increased the outstanding principal balance of the Bridge Loan to $8,000.
VLOC, LLC [Member] | Note Purchase Agreement [Member] | Acacia [Member] | Bridge Loan [Member]
Related Party Transaction [Line Items]
Debt instrument principal balance				$ 8,000,000
Borrowing under line of credit		$ 2,000,000		$ 4,000,000	$ 2,000,000
Intercompany Administrative Services Agreement [Member] | Steel Ventures, LLC [Member]
Related Party Transaction [Line Items]
Related party transaction agreement date											Oct. 1, 2014
Related party transaction agreement term											2 years
Number of renewal options | Option											2
Related party transaction agreement renewal term											2 years
Related party transaction expenses								$ 0		$ 392,000	$ 0	$ 805,000
Related party agreement expiration term											2016-09
Healthcare Plans [Member] | Chad Steelberg and Ryan Steelberg [Member]
Related Party Transaction [Line Items]
Related party transaction expenses								14,000		$ 15,000	$ 29,000	$ 44,000
Due to related party								$ 0			$ 0			$ 73,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	6 Months Ended
	Mar. 31, 2017	Jun. 30, 2017	Jun. 30, 2017	May 17, 2017
Initial Public Offering [Member]
Other Commitments [Line Items]
Common stock price per share				$ 15
Chad Steelberg and Ryan Steelberg [Member]
Other Commitments [Line Items]
Estimated common stock calculated value	$ 125
Chad Steelberg and Ryan Steelberg [Member] | Time-based Stock Option [Member]
Other Commitments [Line Items]
Percentage of fully diluted shares outstanding that may be purchased	5.00%
Vesting period	3 years	3 years
Options Granted		2,089,638	2,089,638
Chad Steelberg and Ryan Steelberg [Member] | Performance- based Stock Option [Member]
Other Commitments [Line Items]
Percentage of fully diluted shares outstanding that may be purchased	2.50%
Vesting period	5 years	5 years
Vesting rights description		The performance-based stock option would vest upon the earlier of (a) the first date on which the market capitalization of the Company's common stock equals or exceeds $400,000 over five consecutive business days, or (b) five years after the IPO	The performance-based stock option would vest upon the earlier of (a) the first date on which the market capitalization of the Company's common stock equals or exceeds $400,000 over five consecutive business days, or (b) five years after the IPO.
Vesting rights, market capitalization	$ 400,000	$ 400,000	$ 400,000
Vesting rights, consecutive trading days	5 days	5 days
Options Granted		1,044,818	1,044,818
Chad Steelberg and Ryan Steelberg [Member] | Performance- based Stock Option [Member] | Initial Public Offering [Member]
Other Commitments [Line Items]
Common stock price per share	$ 0	$ 0	$ 0
Ryan Steelberg [Member]
Other Commitments [Line Items]
Estimated common stock calculated value		$ 125
Annual salary under agreement	$ 350
Chief Executive Officer [Member]
Other Commitments [Line Items]
Share-based compensation arrangement by share-based payment award, shares issued in period		10,121

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Building Lease Agreement [Member] - Subsequent Event [Member] $ in Thousands	Jul. 24, 2017USD ($)ft²Options
Subsequent Event [Line Items]
Lease provided area of office space (in square feet) | ft²	37,875
Office building lease agreement, initial term	82 months
Office building lease agreement, renewal terms	5 years
Number of lease renewal options (in leases) | Options	2
Total minimum lease payments	$ 9,465
Minimum lease payments expected to be paid over the next twelve months	$ 123